Xyzal (Levocetirizine) Dosing
For adults and children ≥12 years, use 5 mg once daily; children 6-11 years require 2.5 mg once daily; infants 6-11 months need 1.25 mg once daily, and children 1-5 years need 1.25 mg twice daily; patients with renal impairment require dose reduction by half, and those with severe renal impairment (CrCl <10 mL/min) should avoid levocetirizine entirely. 12
Standard Dosing by Age
Adults and Adolescents (≥12 years)
- Standard dose: 5 mg once daily in the evening 1
- For less severe symptoms, 2.5 mg once daily may be appropriate 1
- Do not exceed 5 mg in 24 hours 1
Children 6-11 Years
- Dose: 2.5 mg (½ tablet) once daily in the evening 1
- Do not exceed 2.5 mg in 24 hours 1
- This dosing is supported by efficacy data showing significant symptom improvement in perennial allergic rhinitis 3
Children 1-5 Years
- Dose: 1.25 mg (0.125 mg/kg) twice daily 45
- This regimen demonstrated excellent pharmacokinetic/pharmacodynamic profile with 100% median wheal inhibition 5
- Well tolerated in clinical trials with safety profile similar to placebo 4
Infants 6-11 Months
- Dose: 1.25 mg once daily 4
- Safety established in controlled trials, though TEAEs were similar between levocetirizine and placebo 4
Children <6 Months
- Do not use 1
Renal Impairment Dosing
Critical adjustment required: Levocetirizine is renally eliminated, making dose modification essential in renal dysfunction 222
Moderate Renal Impairment (CrCl 10-50 mL/min)
Severe Renal Impairment (CrCl <10 mL/min)
- Avoid levocetirizine entirely 222
- The drug should not be used in this population due to accumulation risk
Patients with Kidney Disease
- Do not use per FDA labeling 1
Elderly Patients (≥65 Years)
- Consult physician before use 1
- Consider lower doses due to age-related decline in renal function
- Start with 2.5 mg daily if renal function is compromised
Key Clinical Considerations
Timing matters: Levocetirizine is taken once daily in the evening for optimal symptom control during typical peak allergy hours 1. The drug reaches peak plasma levels within 1 hour in children 5, providing rapid onset of action.
Dose escalation in refractory cases: While the FDA label specifies maximum doses, clinical practice guidelines note it has become common to increase antihistamine doses above manufacturer recommendations when benefits outweigh risks, though this is off-label 22. However, start with standard dosing first.
Common pitfall: Failing to adjust for renal function is the most critical error. Always calculate creatinine clearance before prescribing, as levocetirizine accumulation in renal impairment can increase adverse effects without additional benefit 222.
Pregnancy and lactation: Avoid if possible, particularly in first trimester, though no human teratogenicity has been demonstrated 22. Cetirizine (the racemic mixture) is FDA Pregnancy Category B, suggesting levocetirizine carries similar risk profile.